⌘K

Login Start Free

Home/Filings/4/0001104659-19-063335

4//SEC Filing

GOLDBERG MORTON 4

Accession 0001104659-19-063335

CIK 0001372514other

View on SEC.gov Company Profile

Filed

Nov 12, 7:00 PM ET

Accepted

Nov 13, 4:18 PM ET

Size

4.8 KB

Accession

0001104659-19-063335

Insider Transaction Report

Form 4

Period: 2019-11-12

EYEGATE PHARMACEUTICALS INCEYEG

GOLDBERG MORTON

Director

Transactions

Sale
Common Stock
2019-11-12$4.29/sh−2,001$8,584→ 1,961 total

Footnotes (1)

[F1]Effective as of 08/30/2019, the Issuer effected a 1-for-15 reverse split of its common stock. The number of shares reflects the reverse stock split.

Documents

1 file

4
tm1922769-1_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

EYEGATE PHARMACEUTICALS INC

CIK 0001372514

Entity typeother

Related Parties

1

filerCIK 0001619731

Filing Metadata

Form type: 4
Filed: Nov 12, 7:00 PM ET
Accepted: Nov 13, 4:18 PM ET
Size: 4.8 KB

View on SEC.gov